Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07437729

Glycocalyx and Oxidative Stress in Endothelial Function (Part 1)

The Role of Glycocalyx and Oxidative Stress in Endothelial Function (Part 1)

Status
Recruiting
Phase
Study type
Observational
Enrollment
105 (estimated)
Sponsor
Josip Juraj Strossmayer University of Osijek · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary research objective of the project is to determine the role of eGC in microvascular reactivity in CKD (cross-sectional study 1). The main objective of the project is to increase the excellence and interdisciplinarity of scientific work at MEFOS by connecting researchers from different scientific fields, improving conditions and resources for scientific work, and increasing international cooperation, in line with strategic objective 1: raising scientific excellence. The results of the project could provide pathophysiological insight into the development and maintenance of endothelial dysfunction in CKD, as well as identify new biomarkers for CKD.

Detailed description

The primary objective of this project is to determine the role of endothelial glycocalyx (eGC) in impaired microvascular endothelium-dependent reactivity in patients with chronic kidney disease compared to healthy and hypertensive patients without complications (cross-sectional study 1). Specific objective 1.1: Measure the reactivity of the peripheral microcirculation (using a laser Doppler blood flow meter) and the thickness of eGC (using Glycocheck) in the specified groups. Specific objective 1.2: Quantify soluble markers of eGC, oxidative stress, and inflammation from serum samples and peripheral blood mononuclear cells (PBMC), as well as antioxidant capacity in the specified groups. Specific objective 1.3: Determine the relationship between the results of functional tests, eGC, and markers from specific objective 1.2.

Conditions

Timeline

Start date
2025-10-01
Primary completion
2029-09-30
Completion
2029-09-30
First posted
2026-02-27
Last updated
2026-03-02

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT07437729. Inclusion in this directory is not an endorsement.